Nara, Japan

Shinichi Kondo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Axikin Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinichi Kondo. Retrieved from https://idiyas.com/inventor/shinichi-kondo-43fcqnht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shinichi Kondo

Introduction

Shinichi Kondo is a notable inventor based in Nara, Japan. He has made significant contributions to the field of biotechnology, particularly in the regulation of kinases. His work has implications for various therapeutic applications, including chronic obstructive pulmonary disease (COPD), asthma, and cancer.

Latest Patents

Shinichi Kondo holds 1 patent related to the regulation of kinase, specifically the regulated in COPD kinase (RC kinase). His patent focuses on reagents that can regulate human RC Kinase activity and bind to human RC Kinase gene products. This innovation is particularly useful for therapeutic effects in treating diseases where cell signaling is defective.

Career Highlights

Kondo is currently associated with Axikin Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new avenues for treatment in various medical conditions.

Collaborations

Shinichi Kondo has collaborated with notable colleagues, including Shinichi Watanabe and Jeffrey A. Encinas. These partnerships enhance the research and development process, fostering innovation in their respective fields.

Conclusion

Shinichi Kondo's contributions to biotechnology and his innovative patent on RC kinase regulation highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…